Iterum Therapeutics plc
http://www.iterumtx.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Iterum Therapeutics plc
Current, Former US FDA Advisory Committee Members' Reform Idea: Allow Conflicted Experts
Conflicted experts should be allowed to participate as nonvoting members and panels should take a benefit-risk vote on product-specific applications, the majority of respondents said in a survey conducted by 3D Communications.
Back To White Oak: US FDA Adcomms Go Fully In-Person, Starting With Antimicrobials Panel
The 9 September meeting on Iterum Therapeutics' oral sulopenem product for uncomplicated urinary tract infections marks the first fully in-person advisory committee drug review since the COVID-19 pandemic hit in early 2020.
Current, Former US FDA Adcomm Members' Reform Idea: Allow Conflicted Experts To Participate
Conflicted experts should be allowed to participate as nonvoting members and panels should take a benefit-risk vote on product-specific applications, the majority of respondents said in a survey conducted by 3D Communications.
Back To White Oak: US FDA Adcomms Go Fully In-Person, Starting With Antimicrobials Panel
The 9 September meeting on Iterum Therapeutics' oral sulopenem product for uncomplicated urinary tract infections marks the first fully in-person advisory committee drug review since the COVID-19 pandemic hit in early 2020.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice